express gazette logo
The Express Gazette
Sunday, March 1, 2026

Wearable 'SLEEP' patch becomes a bestseller in Australia, company says it sold out six times

BonPatch markets a transdermal sleep patch infused with valerian, passion flower, hops and hemp extracts; the founder highlights a travel-focused bundle and urges therapeutic use only

Health 5 months ago
Wearable 'SLEEP' patch becomes a bestseller in Australia, company says it sold out six times

BonPatch’s peel-and-stick SLEEP patch has become a top seller in Australia, the company says, selling out six times since its launch and drawing glowing customer reviews that credit the product with improving sleep.

Priced at A$50 for a 30-pack — the company cites an equivalent cost of about A$1.65 per patch — the latex-free patches are promoted as a transdermal delivery system that releases a blend of botanicals through the skin to support relaxation and a restful night. BonPatch lists the patch’s formulation as Valerian Extract (40.28 percent), Passion Flower Extract (13.27 percent), Hops Extract (13.27 percent) and Hemp Extract (33.18 percent), with a lavender scent added.

The company says each patch is intended for up to 12 hours of wear and that users should apply the patch before bed and remove it in the morning. BonPatch recommends against driving or operating heavy machinery while wearing SLEEP, and notes adhesive residue can be removed with soap or baby oil. The brand also advises that the patches are for therapeutic purposes only and do not replace a balanced diet; it recommends consulting a medical professional before use if trying to conceive, pregnant or breastfeeding.

BonPatch was founded by entrepreneur and television personality Nicole O’Neil, who told media she developed the product to provide a discreet, natural alternative to pills and stimulants that can leave users groggy or wired. O’Neil said she launched the business in 2023 and that the SLEEP patch was created after research into transdermal nutrient delivery and collaboration with manufacturers and chemists.

Customer reviews quoted by the company and media outlets describe faster sleep onset, fewer awakenings and reduced morning grogginess. The brand also reports repeat purchasing by some users, citing an example of a customer who bought 22 boxes within a year. Such accounts represent consumer experiences and are not presented as clinical evidence of efficacy.

BonPatch markets other wearable formulations alongside SLEEP. The VITALITY patch, also sold in 30-packs at A$50, contains caffeine anhydrous, taurine, glucuronolactone, green tea extract and B-vitamins and is described as providing a steady daytime boost with a peppermint aroma. The company sells a JETSET bundle of 30 SLEEP and 30 VITALITY patches for A$75, which it says reduces the per-patch cost to about A$1.25 and is temporarily offered with a complimentary sleep mask.

The product’s active-ingredient list echoes commonly used herbal sleep aids: valerian has a long history of use for sleep support, passion flower is traditionally associated with calmness, and hops have been used in formulations aimed at circadian rhythm support. Hemp extract is included in the advertised blend; BonPatch’s materials do not describe specific cannabinoid concentrations in the company’s public formulation breakdown.

Transdermal patches for supplements and wellness products have grown in visibility as companies pursue alternative delivery systems, but medical experts advise distinguishing between anecdotal consumer reports and evidence from clinical trials. BonPatch’s marketing materials focus on convenience, discreet wear and gradual release of ingredients.

The company also offers products named GLOW, LOV E, CLARITY, RELAX and DETOX, each positioned to support different aspects of wellbeing such as skin health, libido and cognitive function. BonPatch advertises money-saving bundles and travel-focused options aimed at consumers seeking portable solutions for sleep and daytime energy.

Regulatory frameworks for transdermal wellness patches vary by jurisdiction. BonPatch’s site and product literature emphasize intended therapeutic use and recommend consumers consult health professionals for questions about safety, interactions or use in pregnancy and breastfeeding. The company’s communications also note that individual responses can differ, and they encourage users to follow label directions for wear time and removal.

Sales figures and restock claims cited by the company and covered in press reports reflect retail performance as reported by the brand. Consumer response indicates demand for non-pill sleep supports, while health authorities and clinicians generally recommend that people with persistent sleep problems seek medical evaluation to rule out underlying disorders and to discuss evidence-based treatments.

BonPatch’s founder has described the product strategy as addressing travel and lifestyle needs. She said the goal was to offer flexible, natural and discreet options for people who want help winding down at night or maintaining energy during the day without the side effects some users associate with traditional sleep medications or stimulant products.

Consumers considering transdermal wellness patches are advised to read product labels, check ingredient lists, consult health professionals about potential interactions with medications or medical conditions, and follow guidance on wear time and safe use.


Sources